Tuesday , November 21 2017
Home / Specialties / Podiatry / Dr. Don Fetterolf, Part 3: Amniotic Membrane Use in Ulcer Treatment

Dr. Don Fetterolf, Part 3: Amniotic Membrane Use in Ulcer Treatment

In part three of this exclusive interview, Dr. Don Fetterolf talks about the use of amniotic membrane in the healing of diabetic foot ulcers and the process of using the placenta to create the graphs.

Dr. Fetterolf  is the Chief Medical Officer of MiMedx Group, Inc. a bioengineering and regenerative medicine company that is an integrated developer, manufacturer and marketer of biomaterial-based products in the United States and multiple foreign countries. Dr. Fetterolf is an experienced physician executive with extensive expertise in clinical medicine, health care business management, and medical informatics.